Sign in
4

Changes in Ownership

Axogen, Inc. Filed Acc 0001179110-17-015743

Options or other derivatives

  • VP, Clinical&Translational Sc acquired 16,200 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
DeVinney Erick Wayne VP, Clinical&Translational Sc 2017-12-18 Grant or award · Employee Stock Option (right to purchase) +13,900 13,900 D
DeVinney Erick Wayne VP, Clinical&Translational Sc 2017-12-18 Grant or award · Restricted Stock Units +2,300 2,300 D
Loading xslF345X03/edgar.xml…